Coating Flashcards
Reasons for coating
- Protect ingredients from light and moisture
- Improve organoleptic qualities
- Coloured coatings mask changes in colouration of core and aids identification
- Improves handling characteristics
- Increases mechanical strength and no dusting
Ideal coating method
Must comply with pharmacopeia before and after
Avoid abrasions, edges and crowns
Avoid breaking
Sugar coating
- Sealing of core with hydrophobic coat
Shellac with PVP, Cellulose (or PV), acetate phthalate, acrylates - Subcoating
Smoothing out sharp angles
Use a mixture of solutions and solids or a suspension
Sugar; calcium carbonate, talc or gum acacia
Might increase weight by 50-100% - Smoothing
Application of dilute syrup
Titanium and iron oxides are popular - Polishing
Beeswax or Carnauba wax - Printing
Methods are manual ladling or automated equipment
Film coating (Spray coating)
Spray atomised coating solution evenly across a tablet and allow to dry
Most common method
Logos and break line distinct
Sustained release and gastro resistant
Contents
Typically adds 2-3% w/w
- Solvent – Organic, recently water
- Polymer
- Pigments – insoluble pigments as well as solube dyes
- Plasticizers – With low glass transition temperatures (PEG, propylene glycol, glycerol)
Coating polymers
- Celluloses – hydroxypropyl methyl celluloses, hydroxypropyl celluloses, methyl cellulose
- Vinyl polymers – Polyvinyl alcohol
- Aminoalkyl methacrylate (Eudragit E)
Coating issues with film coating
Coatings may be uneven – fail uniformity of mass or patchy coatings
May be abrasive – chipping or broken
Inadequate drying – tablets may stick together
Press coating
A tablet is used as a core for a new tablet
No solvent required and lower interactions between layers
Enteric coating
Allows tablet to dissolve in the small intestine rather than stomach
- Protect acid labile drugs from stomach i.e. Omeprazole, pantoprazole
- Protect stomach from irritants I.e. aspirin, prednisolone
- Prevention of nausea
- Onset of action is delayed up to 12 hours
- Methacrylic acid – methacrylate copolymer
Targets small intestine and large intestine - Cellulose acetate phthalate
pH specific release (soluble when above 2.5)
Xenoestrogen effects
Insulin resistance
Sustained release advantages
Reduced frequency of dosing
Increased patient compliance
Increased activity of an API overnight
Targets chronic illnesses with breakthrough issues
May lower side effects due to reduced peak plasma concentration
SR disadvantages
Cost per unit much higher and branded only
Some API’s absorbed at specific point of GIT
An overdose poses special problems
Tablets can be very large
May lodge in the oesophagus
Localised high concentration causes irritation
Reversing is an issue
Osmotic pump
Semi permeable membrane/coat
Osmotic potential causes water to enter tablet
Pressure forces the API out